Table 2.
Bioactive Principle | Nanovector | Type of Delivery System | Experimental Model | Reference |
---|---|---|---|---|
Δ-9-Tetrahydrocannabinol |
Lipid nanoparticles | Nanostructured lipid carriers | In vitro | [110] |
Nanoparticles | Lipid NP containing lecithin | In vitro | [111] | |
PLGA NP | In vitro/In vivo | [112] | ||
Cannabidiol loaded PCL NP | In vitro | [113] | ||
Δ9-THC-loaded PLGA NP | In vivo (immunocompetent C57BL/6 mice) | [114] |